| Aug 19 |
CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants
|
| Aug 6 |
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 SECOND QUARTER FINANCIAL STATEMENTS AND CONFERENCE CALL INFORMATION
|
| Jul 29 |
CollPlant Biotechnologies Unveils Inaugural ESG and Sustainability Report
|
| Jun 6 |
CollPlant Successfully Bio-Prints 200cc Commercial-Size Regenerative Breast Implants and Reports Additional Positive Pre-Clinical Data
|
| Jun 5 |
CollPlant Biotechnologies First Quarter 2024 Earnings: Misses Expectations
|
| May 29 |
CollPlant Biotechnologies Ltd. (CLGN) Q1 2024 Earnings Call Transcript
|
| May 29 |
CollPlant Biotechnologies Non-GAAP EPS of -$0.35, revenue of $0.1M misses by $0.53M
|
| May 29 |
CollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate Update
|
| May 16 |
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
|
